📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response. (2020)

First Author: Wallis J

Attributed to: OxCD3: Oxford Centre for Drug Delivery Devices funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejps.2020.105456

PubMed Identifier: 32653563

Publication URI: http://europepmc.org/abstract/MED/32653563

Type: Journal Article/Review

Volume: 152

Parent Publication: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

ISSN: 0928-0987